1. Home
  2. NICE vs BIO Comparison

NICE vs BIO Comparison

Compare NICE & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NICE Ltd

NICE

NICE Ltd

HOLD

Current Price

$110.90

Market Cap

6.4B

Sector

Technology

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$270.07

Market Cap

7.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NICE
BIO
Founded
1986
1952
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
7.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NICE
BIO
Price
$110.90
$270.07
Analyst Decision
Buy
Strong Buy
Analyst Count
14
4
Target Price
$156.07
$358.50
AVG Volume (30 Days)
1.1M
289.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.04
$2.31
Revenue Next Year
$9.72
$3.10
P/E Ratio
$11.21
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$94.65
$211.43
52 Week High
$180.61
$343.12

Technical Indicators

Market Signals
Indicator
NICE
BIO
Relative Strength Index (RSI) 53.65 36.78
Support Level $104.02 $266.71
Resistance Level $114.45 $290.01
Average True Range (ATR) 5.03 9.45
MACD 0.97 -1.37
Stochastic Oscillator 74.42 34.48

Price Performance

Historical Comparison
NICE
BIO

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: